Policy on the determination of the condition(s) for a paediatric investigation plan (PIP) / waiver (scope of the PIP / waiver)
Second European Medicines Agency (EMA) and European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 29 November 2023
Clinical Trials Information System: training and support
Article 57 product data
Clinical Trials Information System (CTIS) sponsor end user training programme - February 2024, European Medicines Agency, Amsterdam, the Netherlands, from 12 February 2024, 09:00 (CET) to 15 February 2024, 13:30 (CET)
Clinical Trials Information System (CTIS) sponsor end user training programme - April 2024, European Medicines Agency, Amsterdam, the Netherlands, from 8 April 2024, 14:00 (CEST) to 11 April 2024, 18:30 (CEST)
Clinical Trials Information System (CTIS) sponsor end user training programme - June 2024, European Medicines Agency, Amsterdam, the Netherlands, from 10 June 2024, 09:00 (CEST) to 13 June 2024, 13:30 (CEST)
Joint HMA/EMA multi-stakeholder workshop on Patient Registries
Human medicines European public assessment report (EPAR): Bemfola, follitropin alfa, Date of authorisation: 26/03/2014, Revision: 11, Status: Authorised
Integrilin (eptifibatide) supply shortage